Yangpumicins F and G, Enediyne Congeners from


Journal

Journal of natural products
ISSN: 1520-6025
Titre abrégé: J Nat Prod
Pays: United States
ID NLM: 7906882

Informations de publication

Date de publication:
27 09 2019
Historique:
pubmed: 7 9 2019
medline: 5 11 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

Enediyne natural products are among the most cytotoxic small molecules and thus excellent payload candidates for the development of antibody-drug conjugates (ADCs). Here we report the isolation and structural elucidation of two new 10-membered anthraquinone-fused enediynes, yangpumicins (YPM) F (

Identifiants

pubmed: 31490685
doi: 10.1021/acs.jnatprod.9b00229
pmc: PMC7170010
mid: NIHMS1582470
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2483-2488

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM115575
Pays : United States

Références

J Antibiot (Tokyo). 1989 Dec;42(12):1768-74
pubmed: 2621160
Org Lett. 2018 Sep 21;20(18):5918-5921
pubmed: 30212211
J Ind Microbiol. 1993 Feb;12(2):99-102
pubmed: 7764159
Biotechnol Bioeng. 2019 Jun;116(6):1304-1314
pubmed: 30712262
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
Trends Pharmacol Sci. 2016 Mar;37(3):231-241
pubmed: 26719219
Bioorg Med Chem Lett. 2019 Feb 1;29(3):466-470
pubmed: 30579797
J Nat Prod. 2002 Apr;65(4):570-2
pubmed: 11975503
Org Lett. 2017 Jan 6;19(1):122-125
pubmed: 28004943
Acc Chem Res. 2019 Jan 15;52(1):127-139
pubmed: 30575399
J Ind Microbiol Biotechnol. 2018 Mar;45(3):141-151
pubmed: 29396746
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
Nat Rev Drug Discov. 2017 May;16(5):315-337
pubmed: 28303026
Bioorg Med Chem Lett. 2015 Jan 1;25(1):9-15
pubmed: 25434000
J Ind Microbiol Biotechnol. 2013 May;40(5):411-25
pubmed: 23526181
Nature. 2015 Nov 19;527(7578):323-8
pubmed: 26536114
Org Lett. 2017 Nov 17;19(22):6192-6195
pubmed: 29086572
Annu Rev Med. 2018 Jan 29;69:191-207
pubmed: 29414262
Curr Opin Immunol. 2016 Jun;40:14-23
pubmed: 26963132
Cancer Lett. 2007 Jul 18;252(2):225-34
pubmed: 17276588

Auteurs

Zilong Wang (Z)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.

Zhongqing Wen (Z)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.

Ling Liu (L)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.

Xiangcheng Zhu (X)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.
Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discovery , Changsha , Hunan 410011 , People's Republic of China.

Xiaohui Yan (X)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.
National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery , Changsha , Hunan 410011 , People's Republic of China.

Yanwen Duan (Y)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.
Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discovery , Changsha , Hunan 410011 , People's Republic of China.
National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery , Changsha , Hunan 410011 , People's Republic of China.

Yong Huang (Y)

Xiangya International Academy of Translational Medicine at Central South University , Changsha , Hunan 410013 , People's Republic of China.
National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery , Changsha , Hunan 410011 , People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH